Nutritional intervention in a patient with severe toxic epidermal necrolysis: A case report

Pham Minh Chau, Thai Duc Luan

Nội dung chính của bài viết

Tóm tắt

A 70-year-old male with hypertension, gout, and stage 3a chronic kidney disease was admitted with fever, cough, and poor appetite. On day 2, he developed widespread bullae and mucosal erosions involving 70% of body surface area (BSA), leading to a diagnosis of severe toxic epidermal necrolysis (TEN). Multidisciplinary management in the intensive care unit included wound care, respiratory support, infection control, and early individualized nutritional therapy. Enteral feeding was initiated on ICU day 4, advancing to 1800 kcal/day (~30 kcal/kg/day) and 1.7 g/kg/day protein, including arginine, glutamine, vitamins C and E, and zinc, while monitoring renal and fluid-electrolyte status. Nitrogen balance was considered non-negative based on Nutrition Focused Physical Exam by the same experienced clinician, supported by stable weight from admission to discharge and rising serum albumin. Inflammatory markers decreased, lesions healed, and oral intake resumed. The patient was discharged in stable condition. This case highlights the feasibility and safety of early high-protein immunonutrition in TEN with chronic kidney disease, underscoring the importance of tailored nutrition as a core component of critical dermatologic care.

Chi tiết bài viết

Tài liệu tham khảo

1. Mockenhaupt M. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Clinical Patterns, Diagnostic Considerations, Etiologic Factors, and Therapeutic Management. Semin Cutan Med Surg. 2014;33:10-6. doi: 10.12788/j.sder.0058.
2. Bastuji-Garin S, et al. Clinical Classification of Cases of Toxic Epidermal Necrolysis, Stevens-Johnson Syndrome, and Erythema Multiforme. Arch Dermatol. 1993;129:92-6. doi:10.1001/archderm.1993.01680220104023.
3. Singer P, et al. ESPEN guideline on clinical nutrition in the intensive care unit. Clin Nutr. 2019;38:48-79. doi: 10.1016/j.clnu.2018.08.037.
4. Wischmeyer PE, et al. American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on Nutrition Screening and Therapy. Anesth Analg. 2018;126:1883-95. doi: 10.1213/ANE.0000000000002743.
5. Grimble RF. Immunonutrition. Curr Opin Gastroenterol. 2005;21:216-22. doi: 10.1097/01.mog.0000153360.90653.82.
6. Fischer M, JeVenn A, Hipskind P. Evaluation of muscle and fat loss as diagnostic criteria for malnutrition. Nutr Clin Pract. 2015;30(2):239-248. doi:10.1177/0884533615573053
7. Ikizler TA, Burrowes JD, Byham-Gray LD, et al. KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update. Am J Kidney Dis. 2020;76(3 Suppl 1):S1-S107. doi:10.1053/j.ajkd.2020.05.006
8. Manzanares W, Hardy G. Update on antioxidant micronutrients in the critically ill. Curr Opin Clin Nutr Metab Care. 2013 Nov;16(6):719-25. doi: 10.1097/MCO.0b013e32836599e5.
9. Sekula P, et al. Survival analysis of patients with SJS/TEN. J Invest Dermatol. 2013;133:1197-204. doi: 10.1038/jid.2012.510.
10. Braga M, Wischmeyer PE, Drover J, et al. Clinical evidence for pharmaconutrition in major elective surgery. JPEN J Parenter Enteral Nutr. 2013;37(5 Suppl):66S-72S. doi:10.1177/0148607113494406
11. Wischmeyer PE. Tailoring nutrition therapy to illness and recovery. Crit Care. 2017;21(Suppl 3):316. doi: 10.1186/s13054-017-1906-8.